Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells

BACKGROUND: In recent years, the development of BMSCs-derived exosomes (EXO) for the treatment of osteosarcoma (OS) is a safe and promising modality for OS treatment, which can effectively deliver drugs to tumor cells in vivo. However, the differences in the drugs carried, and the binding of EXOs to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenkai, Li, Zongguang, Yu, Naichun, Zhang, Linlin, Li, Hongyu, Chen, Yongjie, Gong, Fengqing, Lin, Wenping, He, Xu, Wang, Siyuan, Wu, Yue, Ji, Guangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541697/
https://www.ncbi.nlm.nih.gov/pubmed/37775799
http://dx.doi.org/10.1186/s12951-023-02129-1